Keyphrases
Preeclampsia
100%
Pregnant Women
70%
COVID-19
51%
Indonesia
45%
High-risk Pregnancy
26%
Early Detection
23%
Perinatal Outcome
22%
COVID-19 Infection
22%
Surabaya
21%
Maternal Outcomes
21%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
21%
Atorvastatin
21%
Early Onset
17%
High Risk
16%
Placenta
16%
Maternal Morbidity
14%
During Pregnancy
14%
Dempster-Shafer Method
14%
Magnesium Sulfate
14%
Neonatal Death
14%
Rapid Antigen Test
14%
Expert System
14%
COVID-19 Pandemic
14%
Wound Healing
14%
Placenta Accreta Spectrum
14%
Cardiovascular Risk
14%
Confidence Interval
14%
Early-onset Preeclampsia
14%
Cesarean Delivery
13%
Neonatal Morbidity
13%
Mode of Delivery
12%
Obstetrics
12%
Serum Levels
11%
Late-onset Preeclampsia
11%
Late-onset
11%
Treatment Group
11%
Risk Ratio
11%
Antibody Test
10%
Inclusion Criteria
10%
Neonatal Mortality
10%
Neonatal Outcome
9%
Quantitative PCR
9%
Obstetrics and Gynaecology
9%
Tertiary Referral Hospital
9%
Preeclampsia with Severe Features
9%
Magnesium
9%
General Hospital
9%
2-Methoxyethanol
8%
COVID-19 Cases
8%
Non-COVID-19
8%
Medicine and Dentistry
Pre-Eclampsia
83%
COVID-19
56%
Infection
21%
Patient Referral
18%
Placenta Accreta
16%
Immunoassay
15%
Newborn Death
14%
Obstetric Emergency
14%
Cardiovascular Risk
14%
Magnesium Sulfate
14%
Magnesium
14%
Obstetrics
12%
Maternal Morbidity
12%
Placenta
11%
Premature Labor
10%
Diseases
9%
Cross Sectional Study
9%
Newborn Mortality
9%
Newborn Morbidity
9%
Gestational Age
9%
Obesity
9%
Randomized Controlled Trial
8%
Cohort Analysis
8%
Lymphocyte
8%
Cesarean Section
8%
Body Mass Index
8%
Prematurity
7%
Gestational Diabetes
7%
Patient with Obesity
7%
Maternal Diabetes Mellitus
7%
Pregnancy
7%
Diabetes
7%
Pravastatin
7%
Polypharmacy
7%
Health Care
7%
Fetus Growth
7%
Platelet
7%
Antihypertensive Agent
7%
Analgesia
7%
Spectrum Disorder
7%
Health Care Management
7%
Meta-Analysis
7%
Systematic Review
7%
Wound Healing
7%
Heart Disease
7%
Health Service
7%
Maternal Welfare
7%
Pericarp
7%
Nifedipine
7%
Garcinia
7%
Pharmacology, Toxicology and Pharmaceutical Science
Preeclampsia
66%
Maternal Mortality
28%
Infection
22%
Pravastatin
21%
Treatment Group
15%
High Risk Pregnancy
14%
Magnesium Sulfate
14%
Obesity
11%
SARS Coronavirus
10%
Maternal Morbidity
10%
Maternal Death
10%
Randomized Controlled Trial
9%
Premature Labor
9%
Diabetes Mellitus
9%
2 Methoxyethanol
9%
Mortality Rate
9%
Cross-Sectional Study
9%
Cohort Study
8%
Newborn Morbidity
8%
Hyaline Membrane Disease
7%
Prematurity
7%
Perinatal Morbidity
7%
Newborn Mortality
7%
Hemoglobins
7%
Toxic Injury
7%
Randomized Clinical Trial
7%
Clinical Trial
7%
Placenta Accreta
7%
Protein Tyrosine Kinase
7%
Nifedipine
7%
Antihypertensive Agent
7%
Pregnancy Diabetes Mellitus
7%
Maternal Diabetes Mellitus
7%
Placental Growth Factor
7%
Heart Disease
7%
Wound Healing
7%
Hemoglobin A1c
7%
Xanthone Derivative
7%
Garcinia mangostana
7%
Tablet
7%
Iron
7%
Perinatal Mortality
6%
Placenta Previa
5%
Methylprednisolone
5%
Antihypertensive Drug
5%
Methyldopa
5%